Knee Pain and Weight Management Clinical Trial
A New Research Study for Knee Osteoarthritis & Weight Management
Living with knee pain and carrying extra weight?
You May Be Eligible for a Clinical Trial
Early access to potential new treatments. Be among the first to benefit from medical advancements designed to improve
Expert medical care and monitoring. Receive ongoing support from leading healthcare professionals throughout the trial, ensuring your well-being at every step.
Making a difference for future patients. Your participation helps shape the future of weight loss medicine, providing insights that lead to better treatments for others.
What to expect on your visit
Warm welcome and check in
Our team will will greet you and guide you though the process.
Comfortable waiting area
Relax with seating, refreshments and Wi-Fi whilst you wait.
Meet your specialist
A dedicated professional will explain everything and answer any questions.
Clear instructions
We’ll walk you through each step so you know exactly what to expect
Time for questions
You’ll have the opportunity to ask anything about your participation
Follow-up guidance
We’ll provide details on the next steps and any necessary follow-up visits.
Your questions answered
Apply Now-
A clinical trial protocol is a comprehensive plan that outlines the study’s objectives, design, methodology, statistical considerations, and organisation. It specifies:
- The purpose of the study
- Eligibility criteria for participants
- Details of tests, procedures, medications, and dosages
- The schedule of activities
- Information to be collected about participants
This protocol ensures the study is conducted consistently and safely across all participants.
-
Clinical trials encompass various study types, including:
- Prevention Trials: Explore methods to prevent diseases in individuals who have not had them or to prevent recurrence.
- Treatment Trials: Test new treatments, drug combinations, or approaches to therapy.
- Diagnostic Trials: Seek better tests or procedures for diagnosing specific conditions.
- Screening Trials: Evaluate ways to detect diseases or health conditions.
- Quality of Life Trials: Aim to improve comfort and life quality for individuals with chronic illnesses.
Many trials compare a new product or therapy to existing treatments or placebos to determine effectiveness. Potential participants are informed beforehand if placebos are part of the study design.
-
Participating in a clinical trial offers several potential benefits:
- Access to New Treatments: You may receive investigational therapies not yet available to the public, potentially improving your health condition.
- Contribute to Medical Research: Your involvement aids in understanding how treatments work across different populations, helping to develop better therapies for future patients.
- Comprehensive Care: Participants receive close monitoring and additional healthcare assessments related to the study.
- Voluntary Participation: You can withdraw from the study at any time without any obligation.
Each study has specific eligibility criteria, so not everyone who applies will be accepted.
-
Clinical trials progress through several phases, each designed to answer specific research questions:
- Phase 1: Involves a small group (20-80 participants), often healthy volunteers or patients with advanced diseases. The focus is on evaluating safety, identifying side effects, determining safe dosage ranges, and understanding how the body processes the investigational product. This phase typically lasts several months, with about 70% of studies advancing to Phase 2.
- Phase 2: Enrols 100-300 participants with the condition under study to further assess safety and effectiveness. These trials may be randomised and controlled, comparing the investigational product to standard treatments or placebos. Blinding is often used to prevent bias. Phase 2 studies usually take up to two years, with approximately 33% progressing to Phase 3.
- Phase 3: Includes larger groups (thousands of participants) to confirm effectiveness, monitor side effects, and compare the investigational product to standard treatments. These randomised and blinded trials can last from one to four years, with 25-30% successfully leading to regulatory approval submissions.
- Phase 4: Conducted after regulatory approval, these post-marketing studies gather additional information on risks, benefits, and optimal use in various populations over extended periods. Findings can influence whether a product remains on the market or if usage guidelines need adjustments.
-
A clinical trial is a medical research study involving volunteers to explore new ways to prevent, detect, or treat diseases, illnesses or ailments. These studies assess investigational treatments, which may include new drugs, combinations of drugs, new delivery methods for existing medications, or medical devices. Before approval, these treatments undergo rigorous testing to ensure they are safe and effective. Each trial follows a detailed protocol outlining the study’s purpose, participant criteria, procedures, and duration. A principal investigator, often a medical doctor, leads the research team, which includes various healthcare professionals. Participation is entirely voluntary, and diverse involvement is crucial to understand different responses to the investigational product.
Trial details overview
What’s this clinical trial about?
If you’re living with ongoing knee osteoarthritis (OA) pain, wear and tear arthritis, and are overweight or living with obesity, you may be able to take part in a new clinical trial.
This trial is looking at whether a once-weekly investigational treatment may help alleviate knee pain over time through weight loss, compared with a placebo (a look-alike treatment with no active medicine).
You’ll also receive regular health checks and support from experienced healthcare professionals throughout the study.
Why is this study important?
Around the world, the rates of obesity are rising. This has been linked to:
- An increasing number of people developing type 2 diabetes (T2D)
- Higher risk of certain cancers
- Increased risk of premature death
Carrying extra weight can also put additional strain on the knees, potentially worsening osteoarthritis pain.
This trial is designed to explore whether addressing weight may also help improve knee OA symptoms in adults who do not have type 2 diabetes.
Who May Be Eligible?
You may qualify if you:
- Are 18 years or older
- Have a BMI of 27 or more
- Have had knee pain for at least 12 weeks
- Experience moderate knee pain or wear and tear arthritis most days
- Have tried dieting at least once without long-term success
- Do not have type 1 or type 2 diabetes
Who Would Not Be Eligible?
You would not be able to take part if you:
- Have type 1 or type 2 diabetes
- Have had knee replacement surgery in the affected knee
- Recently received steroid or certain knee injections
- Are currently taking prescription weight-loss medications
- Have certain heart, liver, kidney, endocrine, autoimmune, or psychiatric conditions
- Are pregnant, planning pregnancy, or breastfeeding
This is not a complete list. The study team will carefully assess your health history to ensure participation is appropriate and safe.
In the news
Panthera Biopartners Expands European Footprint with Acquisition of Hungary’s Leading Clinical Research Organisation, OEC
Panthera Expands Glasgow Clinical Research Operations with Move to Health Innovation Hub (HiH)
Why the UK is winning back global clinical trials
Available Panthera Locations